Literature DB >> 8601569

The prognostic significance of DNA ploidy in adenocarcinomas of the esophagogastric junction.

M Sarbia1, G Molsberger, R Willers, O Horstmann, C Schroders, R Porschen, E Gabbert H.   

Abstract

DNA aneuploidy, as determined by flow cytometry, was detected in 36 out of 59 adenocarcinomas of the esophagogastric junction (61.0%). DNA aneuploidy was more frequent in tumors with infiltrative growth pattern and in high pT categories. No correlation was found with pN category, grading and Laurén's classification. In contrast to clinicopathological parameters, DNA ploidy has no impact on patients survival in univariate survival analysis.

Entities:  

Mesh：

Year:  1996        PMID： 8601569     DOI： 10.1007/bf01366961

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  14 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  [Dna ploidy in adenocarcinoma of Barrett's esophagus].

Authors:  J F Flejou; B Doublet; F Potet; J Metayer; J Hemet
Journal:  Ann Pathol       Date:  1990       Impact factor: 0.407

4.  Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.

Authors:  Y Yonemura; S Ooyama; K Sugiyama; T Kamata; X De Aretxabala; H Kimura; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

5.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

6.  Changes in the location and type of gastric adenocarcinoma.

Authors:  D A Antonioli; H Goldman
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

7.  The prognostic significance of tumor ploidy and pathology in adenocarcinoma of the esophagogastric junction.

Authors:  A L Schneeberger; R J Finley; M Troster; R Lohmann; M Keeney; R I Inculet
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

8.  Limited esophagogastrectomy for carcinoma of the cardia. Indications, technique, and results.

Authors:  F H Ellis; S P Gibb; E Watkins
Journal:  Ann Surg       Date:  1988-09       Impact factor: 12.969

9.  The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis.

Authors:  N C Armitage; K C Ballantyne; D F Evans; P Clarke; J Sheffield; J D Hardcastle
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

10.  Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.

Authors:  J Powell; C C McConkey
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640
View more
  4 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.

Authors:  L J Williams; D L Guernsey; A G Casson
Journal:  Curr Oncol       Date:  2006-02       Impact factor: 3.677

3.  Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.

Authors:  K H Lee; J S Lee; J H Lee; S W Kim; C Suh; W K Kim; S H Kim; Y I Min; B S Kim; K C Park; M S Lee; H S Sun
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

4.  The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.

Authors:  Jon M Davison; Melissa Yee; J Michael Krill-Burger; Maureen A Lyons-Weiler; Lori A Kelly; Christin M Sciulli; Katie S Nason; James D Luketich; George K Michalopoulos; William A LaFramboise
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.